03:57 AM EDT, 09/13/2024 (MT Newswires) -- MBX Biosciences (MBX) said late Thursday it priced its initial public offering of 10.2 million common shares at $16 per share for expected gross proceeds of $163.2 million.

The company granted the underwriters a 30-day option to buy an additional about 1.5 million shares.

The shares are expected to start trading on the Nasdaq Global Select Market on Friday under the ticker symbol "MBX." The offering is expected to close on Sept. 16.